Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Annabelle Singer
Georgia Institute of Technology, Department: Engineering (All Types)
Should you be removed from our database? Contact us at [email protected]. Read more below.
Cognito Therapeutics, Inc.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Cognito is involved in commercialization and clinical research with a technology that uses flickering lights at gamma frequency to drive neural activity to alter Alzheimer's pathology. Dr. Singer holds equity in Coginto Therapeutics, LLC. (Cognito). The company technologies are related to those being studied in this project.
The Committee reviewed the goals of this project, Dr. Singer's role on it, and her equity interest in Cognito. The Committee determined that Dr. Singer has a Financial Conflict of Interest (FCOI) on this project because she holds equity in a company that is commercializing technologies related to those being studied and the results of this project could inform the company’s commercialization efforts. Her financial interest in Cognito could bias or appear to bias the design, conduct, or reporting of this research.
Non-Invasive Methods to Drive Neural Activity with Millisecond Precision and to Recruit the Brain’s Immune Cells
Project Narrative The proposed research will provide, for the first time, non-invasive methods to drive neural activity with millisecond precision in deep brain structures and to recruit the brain?s immune cells. This non-invasive stimulation will readily translate to humans to spur new research with wide-ranging impact and therapies for multiple neurological diseases.
Filed on October 22, 2018.
Tell us what you know about Annabelle Singer's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Annabelle Singer”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Annabelle Singer | Georgia Institute of Technology | Conflict of Interest | COGNITO THERAPEUTICS LTD |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.